Showing results (11-20 of 260) with videos related to
Sort By:
Pageof 26
Oncoimmunology|February 6, 2014
When breast cancer cells start to fend the educational process of NK cells offEmilie Mamessier, Charlotte Bourgin, Daniel OliveExpert Opinion on Biological Therapy|November 19, 2019
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapyFlorent Amatore, Laurent Gorvel, Daniel OliveMedecine Sciences : M/S|January 7, 2020
[Next generation of anti-immune checkpoints antibodies]Nathalie Bonnefoy, Daniel Olive, Bernard VanhoveInternational Journal of Molecular Sciences|January 28, 2026
The Phylogenomic Approach Suggests That Butyrophilins Have Ligands Beyond Gamma-Delta ReceptorsLudovic Marenco, Daniel Olive, Pierre PontarottiExpert Opinion on Therapeutic Targets|February 23, 2018
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapyFlorent Amatore, Laurent Gorvel, Daniel OliveCurrent Molecular Medicine|October 29, 2009
Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targetingChristine Pasero, Alemseged Truneh, Daniel OliveFrontiers in Immunology|November 3, 2022
Major pathways involved in macrophage polarization in cancerClément Kerneur, Carla E Cano, Daniel OliveOncoimmunology|November 19, 2013
BTLA, a key regulator of Vγ9Vδ2 T-cell proliferationJulie Gertner-Dardenne, Cyril Fauriat, Daniel OliveDiscovery Medicine|August 14, 2010
Natural killer cells and immunity against cancerRegis T Costello, Cyril Fauriat, Daniel OliveImmunity|April 18, 2019
An X-ray Vision for Phosphoantigen RecognitionMichael L Dustin, Emmanuel Scotet, Daniel OlivePageof 26